Profil
Steve is a former member of the executive management committee for Global Banking and Markets at Bank of America Merrill Lynch where he was Chief of Staff and led the Chief Operating Officer organization.
Steve held key management positions in the Merrill Lynch organization including: Head of Americas Equity Sales (all products), Head of Americas Equity Research, and Head of Global Pharmaceutical Research (#1 ranked pharmaceutical research analyst according to Institutional Investor, Reuters & Greenwich Associates).
Steve also worked on major cost reductions programs at Bank of America (project New BAC, $8 BB in savings) and Humana (Project Sparc) while at BofA and at Vici Capital Partners.
Steve started his investment banking career at J.P.
Morgan & Company where he worked on numerous corporate finance and M&A transactions.
Prior to going to Wall Street, Steve was a Member of the Technical Staff in the basic research division of AT&T Bell Laboratories in Murray Hill, NJ.
Steve holds an MBA from the Wharton Business School and B.S.
and M.S.
degrees in Chemical Engineering from UCSD.
Anciens postes connus de Steve Tighe
| Sociétés | Poste | Fin |
|---|---|---|
Zumbro Discovery, Inc.
 Zumbro Discovery, Inc. Pharmaceuticals: MajorHealth Technology Zumbro Discovery, Inc. discovers and develops novel peptides for cardiovascular and metabolic disease. It focuses on developing a peptide for the treatment of resistant hypertension. The company was founded by John C. Burnett Jr. and Horng H. Chen on February 1, 2013 and is headquartered Rochester, MN. | Consultant / Advisor | 01/01/2017 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Directeur de la Recherche - Actions | 16/05/2012 |
| J.P. Morgan & Co., Inc. (Old) | Corporate Officer/Principal | 30/08/1996 |
Bell Laboratories
 Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Bell Laboratories provides research and development services. It provides communications technologies including transistors, digital networking, signal processing, lasers and fiber-optic communications systems, communication satellites, cellular telephony, electronic switching of calls, touch-tone dialing and modems. The company was founded in 1925 and is headquartered in Murray Hill, NJ. | Corporate Officer/Principal | 31/07/1986 |
Formation de Steve Tighe
| University of Pennsylvania | Masters Business Admin |
| University of California, Berkeley | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bell Laboratories
Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Bell Laboratories provides research and development services. It provides communications technologies including transistors, digital networking, signal processing, lasers and fiber-optic communications systems, communication satellites, cellular telephony, electronic switching of calls, touch-tone dialing and modems. The company was founded in 1925 and is headquartered in Murray Hill, NJ. | Commercial Services |
| J.P. Morgan & Co., Inc. (Old) | Finance |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |
Zumbro Discovery, Inc.
Zumbro Discovery, Inc. Pharmaceuticals: MajorHealth Technology Zumbro Discovery, Inc. discovers and develops novel peptides for cardiovascular and metabolic disease. It focuses on developing a peptide for the treatment of resistant hypertension. The company was founded by John C. Burnett Jr. and Horng H. Chen on February 1, 2013 and is headquartered Rochester, MN. | Health Technology |